Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
0.4278
-0.0291 (-6.37%)
At close: Mar 28, 2025, 4:00 PM
0.4301
+0.0023 (0.54%)
Pre-market: Mar 31, 2025, 8:22 AM EDT

Generation Bio Co. Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Revenue
19.895.9---
Upgrade
Revenue Growth (YoY)
236.92%----
Upgrade
Cost of Revenue
47.7776.9470.5674.7249.14
Upgrade
Gross Profit
-27.88-71.04-70.56-74.72-49.14
Upgrade
Selling, General & Admin
51.3167.5370.6244.3831.98
Upgrade
Operating Expenses
51.3167.5370.6244.3831.98
Upgrade
Operating Income
-79.19-138.56-141.18-119.1-81.11
Upgrade
Other Non Operating Income (Expenses)
10.7211.954.54-0.050.59
Upgrade
EBT Excluding Unusual Items
-68.47-126.61-136.64-119.15-80.52
Upgrade
Other Unusual Items
-63.2----
Upgrade
Pretax Income
-131.67-126.61-136.64-119.15-80.52
Upgrade
Net Income
-131.67-126.61-136.64-119.15-80.52
Upgrade
Net Income to Common
-131.67-126.61-136.64-119.15-80.52
Upgrade
Shares Outstanding (Basic)
6764585627
Upgrade
Shares Outstanding (Diluted)
6764585627
Upgrade
Shares Change (YoY)
3.32%10.96%3.23%106.54%476.06%
Upgrade
EPS (Basic)
-1.98-1.96-2.35-2.12-2.95
Upgrade
EPS (Diluted)
-1.98-1.96-2.35-2.12-2.95
Upgrade
Free Cash Flow
-90.96-60.14-111.25-97.78-75.66
Upgrade
Free Cash Flow Per Share
-1.36-0.93-1.91-1.74-2.78
Upgrade
Gross Margin
-140.16%----
Upgrade
Operating Margin
-398.12%-2346.93%---
Upgrade
Profit Margin
-661.91%-2144.51%---
Upgrade
Free Cash Flow Margin
-457.29%-1018.66%---
Upgrade
EBITDA
-74.26-133.3-136.05-114.57-77.68
Upgrade
D&A For EBITDA
4.935.265.134.533.43
Upgrade
EBIT
-79.19-138.56-141.18-119.1-81.11
Upgrade
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q